Philipp Berger

Dr. Philipp Berger


Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 November 2006 in Nature Methods
Verified
Journal Article
Closed access
PDF file
DFDaniel J Fitzgerald
Daniel J Fitzgerald
PBPhilipp Berger
Philipp Berger
CSChristiane Schaffitzel
Christiane Schaffitzel
KYKazuhiro Yamada
Kazuhiro Yamada
TRTimothy J Richmond
Timothy J Richmond
IBImre Berger
Imre Berger

13 February 2014 in Nature Protocols
Verified
Journal Article
Closed access
ARAurélien Rizk
Aurélien Rizk
GPGrégory Paul
Grégory Paul
PIPietro Incardona
Pietro Incardona
MBMilica Bugarski
Milica Bugarski
MMMaysam Mansouri
Maysam Mansouri
ISIvo F Sbalzarini
Ivo F Sbalzarini

1 April 2003 in Molecular and Cellular Neuroscience
Verified
Journal Article
Closed access
DLDino P Leone
Dino P Leone
SGS.Téphane Genoud
S.Téphane Genoud
SASuzana Atanasoski
Suzana Atanasoski
RGReinhard Grausenburger
Reinhard Grausenburger
PBPhilipp Berger
Philipp Berger
USUeli Suter
Ueli Suter

21 July 2011 in Blood
Verified
Journal Article
Open access
PDF file
KBKurt Ballmer-Hofer
Kurt Ballmer-Hofer
AAAnneli E. Andersson
Anneli E. Andersson
LRLaura E. Ratcliffe
Laura E. Ratcliffe
PBPhilipp Berger
Philipp Berger
Vascular endothelial growth factors (VEGFs) regulate blood and lymph vessel development by activating 3 receptor tyrosine kinases (RTKs), VEGFR-1, -2, and -3, and by binding to coreceptors such as neuropilin-1 (NRP-1). We investigated how different VEGF-A isoforms, in particular VEGF-A165a and VEGF-A165b, control the balance between VEGFR-2 recycling, degradation, and signaling. Stimulation of cells with the NRP-1–binding VEGF-A165a led to sequential NRP-1–mediated VEGFR-2 recycling through Rab5, Rab4, and Rab11 vesicles. Recycling was accompanied by dephosphorylation of VEGFR-2 between Rab4 and Rab11 vesicles and quantitatively and qualitatively altered signal output. In cells stimulated with VEGF-A165b, an isoform unable to bind NRP-1, VEGFR-2 bypassed Rab11 vesicles and was routed to the degradative pathway specified by Rab7 vesicles. Deletion of the GIPC (synectin) binding motif of NRP-1 prevented transition of VEGFR-2 through Rab11 vesicles and attenuated signaling. Coreceptor engagement was specific for VEGFR-2 because EGFR recycled through Rab11 vesicles in the absence of known coreceptors. Our data establish a distinct role of NRP-1 in VEGFR-2 signaling and reveal a general mechanism for the function of coreceptors in modulating RTK signal output.


6 October 2003 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PBPhilipp Berger
Philipp Berger
CSChristiane Schaffitzel
Christiane Schaffitzel
IBImre Berger
Imre Berger
NBNenad Ban
Nenad Ban
USUeli Suter
Ueli Suter
Mutations in the myotubularin (MTM)-related protein 2 ( MTMR2 ) gene are responsible for the severe autosomal recessive neuropathy Charcot–Marie–Tooth disease type 4B1. MTMR2 belongs to the MTM family of dual-specific phosphatases that use phosphatidylinositol (PI) 3,5-bisphosphate [PI(3,5)P 2 ] and PI 3-phosphate [PI(3)P] as their substrate. Because these substrates are localized in the membrane bilayer, membrane targeting of Mtmr2 is an important regulatory mechanism. In hypoosmotically stressed COS cells with increased levels of PI(3,5)P 2 , Mtmr2 is bound to the membrane of vacuoles formed under these conditions. Using several mutant forms of Mtmr2, we identified two domains that are necessary for membrane association: ( i ) A pleckstrin homology-GRAM domain; and ( ii ) a coiled-coil module. Protein-lipid overlay assays show that the pleckstrin homology-GRAM domain binds to PI(3,5)P 2 and PI(5)P, a substrate and a product of the Mtmr2 enzyme, respectively. We also demonstrate that Mtmr2 forms a dimer and that the C-terminal coiled-coil is responsible for homodimerization, in addition to membrane association. Our data indicate that phosphoinositide–protein interactions, as well as protein–protein interactions, are necessary for the correct regulation of MTMR2.